ClinicalTrials.Veeva

Menu

Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk (NAMU)

U

University Hospital of Cologne

Status

Unknown

Conditions

Hydrocephalus in Infants

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04229693
UHC_NAMU

Details and patient eligibility

About

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.

Full description

Since the nasal route might be highly effective for neurotrophins and other growth factors the cerebrospinal fluid will be investigated using mass spectrometry to identify modulating effects of intranasal breast milk application on the cerebrospinal fluid proteom.

Enrollment

20 estimated patients

Sex

All

Ages

3 days to 12 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • preterm infant with hydrocephalus and regular drainage

Exclusion criteria

  • Inborn error of metabolism

Trial contacts and locations

1

Loading...

Central trial contact

Angela Kribs, MD; Titus Keller, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems